首页> 外文会议>IEEE International Symposium on Circuits and Systems >Detection of Breast Cancer ESR1 p.E380Q Mutation on an ISFET Lab-on-Chip Platform
【24h】

Detection of Breast Cancer ESR1 p.E380Q Mutation on an ISFET Lab-on-Chip Platform

机译:在ISFET芯片实验室平台上检测乳腺癌ESR1 p.E380Q突变

获取原文

摘要

This paper presents a method for detection of ESR1 p.E380Q, a common Breast Cancer (BC) mutation, using an ISFET (Ion-Sensitive Field-Effect Transistor) based Lab-on-Chip (LoC) platform. The LoC contains an ISFET array that can detect pH changes during DNA amplification, specifically Loop-Mediated Isothermal Amplification (LAMP). Synthetic ESR1 DNA was detected in a comparison pH-LAMP assay, carried out on the LoC platform as well as a conventional qPCR instrument. Positive detection of the allele arises due to bespoke allele-specific primers that target one base-pair difference between the wild-type and mutant alleles. The LoC and qPCR demonstrate comparable results detecting the mutant allele with mutant primers in around 25 minutes. The sensing microchip technology coupled with the molecular methods of isothermal chemistries and primer design allow this platform to be tested at a Point-of-Care setting for breast cancer patients, offering mutational tracking platform of circulating tumour DNA in liquid biopsies to assist patient stratification and allow tailored treatments.
机译:本文介绍了一种基于ISFET(离子敏感场效应晶体管)芯片实验室(LoC)平台的ESR1 p.E380Q(一种常见的乳腺癌(BC)突变)检测方法。 LoC包含一个ISFET阵列,可以检测DNA扩增过程中的pH变化,特别是环介导的等温扩增(LAMP)。在比较pH-LAMP分析中检测合成的ESR1 DNA,该分析在LoC平台和常规qPCR仪器上进行。对等位基因的阳性检测是由于针对野生型和突变型等位基因之间一个碱基对差异的定制等位基因特异引物而引起的。 LoC和qPCR证明了在约25分钟内用突变引物检测突变等位基因的可比结果。传感微芯片技术与等温化学的分子方法和引物设计相结合,使该平台可以在乳腺癌患者的即时护理环境中进行测试,提供液体活检中循环肿瘤DNA的突变跟踪平台,以帮助患者分层和允许量身定制的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号